Mounjaroمونجارو

Brand medicine

Active ingredient: Tirzepatide

Registered in Jordan (specific products only)2.5mg, 5mg, 7.5mg, 10mg, 12.5mg, 15mgSubcutaneous injection · Pre-filled pen

Written by JordanMedHub Medical Team

Medically reviewed by JordanMedHub Medical Team

Last updated 9/25/2026

Available forms

2.5mgPre-filled pen

5mgPre-filled pen

7.5mgPre-filled pen

10mgPre-filled pen

12.5mgPre-filled pen

15mgPre-filled pen

Weight management and obstructive sleep apnea are indications of the separate brand Zepbound, not of Mounjaro.

Adjunct to diet and exercise to improve glycemic control in adults and pediatric patients 10 years of age and older with type 2 diabetes mellitus
To reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal heart attack, or non-fatal stroke) in adults with type 2 diabetes mellitus who are at high risk for these events

Shared warnings (thyroid C-cell tumor boxed warning, pancreatitis, hypoglycemia, and others) are on the tirzepatide ingredient page.

The US label lists single-dose pens and vials, multi-dose vials, and a KwikPen. Which of these, if any, are available in Jordan has not been verified here.
Never share a Mounjaro KwikPen between patients.

Shown for reference only. Registration is product-specific. Confirm the current status in the official JFDA registry or with your pharmacist.

2.5mg